Skip to content
Federal Criminal Trialtrial-daytrial-dayJohn C. BosticRobert S. LeachKevin M. DowneyKatherine TrefzJames MattisJustin OffendirectcrossredirectDay 10 - September 22, 2021The court resolved text-message completeness and admissibility issues, Justin Offen authenticated PwC’s reconstructed message evidence, and James Mattis described his reliance on Theranos representations and eventual loss of confidence.
← Day 9Federal Criminal TrialDay 11 →

Day 10 - September 22, 2021

Text-Message Rulings, Device Evidence, and James Mattis’s Board Testimony

Judge Edward J. Davila
7Proceedings
4Pages
2Witnesses
2,498Lines
Day 10 of 51
Appearing:

The court resolved text-message completeness and admissibility issues, Justin Offen authenticated PwC’s reconstructed message evidence, and James Mattis described his reliance on Theranos representations and eventual loss of confidence.

Full day summary

Before the jury entered, the court reviewed proposed text-message evidence and issued Rule 106 completeness rulings while reserving separate objections under Rules 401, 403, and 404(b). It allowed journalist-related messages for notice and knowledge with a limiting instruction, ordered one name redacted, and later admitted disputed messages subject to stated limits. Justin Offen described PwC’s forensic imaging of six devices assigned to Holmes and its reconstruction of messages believed to be between Holmes and Ramesh Balwani. He explained the extraction and matching process, and the court ultimately admitted Exhibit 5387B in redacted form and Exhibit 5387A for authentication while preserving message-specific objections. On cross-examination, Offen acknowledged that the reconstruction used UTC timestamps and did not establish the sequence of messages sharing an identical timestamp. James Mattis testified that he supported only a regulated, side-by-side military experiment until Theranos technology proved accurate and reliable. He said he later joined the board, invested approximately $85,000, and initially relied on Holmes for information about the company. Mattis understood that Theranos analyzers could perform a broad test menu and said disclosure of substantial third-party equipment use or limited Edison capability would have mattered to the board. Cross-examination established his lack of laboratory and engineering expertise, his board compensation, and his dependence on others for technical assessment. On redirect, he said repeated surprises and insufficient transparency left him unsure by approximately mid-2016 what to believe about the technology.

3. James Mattis — Direct/Cross/Redirect

James Mattis completed direct, cross, and redirect testimony about Theranos's claims, the unrealized military test, his board service, and his eventual loss of confidence. Justin Offen's interrupted examination then resumed.

Direct
James MattisJohn C. Bostic
793 lines

James Mattis described how Holmes's claims about a small, broadly capable analyzer led him to support a military pilot, join the Theranos board, and invest, before disclosures about third-party equipment and unresolved accuracy questions eroded his confidence.

Cross
James MattisKevin M. Downey
724 lines

James Mattis acknowledged his limited technical expertise, board compensation, and reliance on others while describing demands for comparison testing, board validation efforts, and the response to criticism of Theranos.

Redirect
James MattisJohn C. Bostic
65 lines

James Mattis clarified that proposed military testing was never completed, described the board assumptions behind his support for Theranos, and said repeated surprises and insufficient transparency later left him unsure what to believe.

Highlights

James Mattis — Directtestimony highlightMattis explained that he advocated only a side-by-side military pilot, not diagnostic use, because the technology needed to prove its accuracy, speed, and reliability before treating casualties.James Mattis — Direct“YOU DON'T TAKE CHANCES ON SOMETHING LIKE THAT. IT NEEDS TO PROVE ITSELF BEFORE IT'S BROUGHT IN, AND THERE'S A CERTIFICATION PROCESS IT HAS TO GO THROUGH, BUT I WANTED TO GET IT STARTED.”— James MattisMattis described proof and certification as prerequisites for military medical use despite his initial enthusiasm.James Mattis — Directtestimony highlightUsing the 2013 board presentation, the government elicited Mattis's understanding that Theranos's own analyzers could run a broad test menu and his testimony that disclosure of a 12-test limitation or substantial third-party analyzer use would have mattered to him.James Mattis — Redirecttestimony highlightMattis acknowledged that he initially remained supportive after The Wall Street Journal reporting, but said that by mid-2016 he no longer knew what to believe because of repeated surprises and insufficient transparency with the board.James Mattis — Redirect“THERE HAD BEEN TOO MANY SURPRISES. THERE WAS NOT THE TRANSPARENCY WITH THE MEMBERS OF THE BOARD THAT WOULD HAVE ALLOWED US TO BE IN FRONT OF THESE ISSUES AND TO HELP THE CEO TO HELP GUIDE THE COMPANY THROUGH THESE KIND OF THINGS.”— James MattisMattis attributed his changed view to repeated surprises and a lack of transparency with the board.

4. Justin Offen — Direct/Cross (Recall)

Justin Offen completed direct examination about reconstructed Holmes-Balwani messages and then testified on cross-examination about timestamp sorting and uncertainty in the order of identically timed messages.

Direct
Justin OffenRobert S. Leach
175 lines

Justin Offen identified and presented Holmes-Balwani messages concerning laboratory operations, responsibility, and validation concerns. The court admitted redacted Exhibit 5387B and admitted Exhibit 5387A for authentication purposes while preserving message-specific objections.

Cross
Justin OffenKatherine Trefz
99 lines

Justin Offen explained the reconstructed spreadsheet's identifiers, UTC timestamps, and sorting conventions. He acknowledged that identical timestamps did not establish which message Holmes or Balwani viewed first.

Highlights

← Day 9Federal Criminal TrialDay 11 →